Gepubliceerd:
Laatst bijgewerkt:
Metabolic changes are thought to precede morphological or changes in tumor size. MR spectroscopy can monitor metabolic changes
ID
NL-OMON25351
Bron
NTR
Verkorte titel
Spectro
Aandoening
breast cancer; neoadjuvant therapy;
borstkanker; neo-adjuvante therapy
Ondersteuning
Primaire sponsor
:
UMC Utrecht
Overige ondersteuning
:
Dutch scientific organisation (NWO), VENI, dr. Klomp
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
a) What changes in phospomonoester / phosphodiester ratio can be detected with 7T MRS during neo-adjuvant therapy in breast cancer? <br>
b) What is the correlation of these changes to the treatment efficacy as determined by pathology?
Doel van het onderzoek
Metabolic changes are thought to precede morphological or changes in tumor size. MR spectroscopy can monitor metabolic changes
Onderzoeksopzet
Patients get a MRS scan prior to-, half way-, and after chemotherapy.
Onderzoeksproduct en/of interventie
none
Publiek
UMC Utrecht <br>
Heidelberglaan 100
W.J.M. Kemp, van der
Utrecht
The Netherlands
088-7556674
w.j.m.vanderkemp@umcutrecht.nl
Heidelberglaan 100
W.J.M. Kemp, van der
Utrecht
The Netherlands
088-7556674
w.j.m.vanderkemp@umcutrecht.nl
Wetenschappelijk
UMC Utrecht <br>
Heidelberglaan 100
W.J.M. Kemp, van der
Utrecht
The Netherlands
088-7556674
w.j.m.vanderkemp@umcutrecht.nl
Heidelberglaan 100
W.J.M. Kemp, van der
Utrecht
The Netherlands
088-7556674
w.j.m.vanderkemp@umcutrecht.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- 18 year or older
- Female
- Neoadjuvant therapy for breast cancer
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- Prior surgery for malignancy to ipsilateral breast
- Karnofsky score =< 70
- Pregnant or lactating
- Other contraindications for MR
Opzet
Type
:
Observationeel onderzoek, zonder invasieve metingen
Onderzoeksmodel
:
Anders
Toewijzing
:
N.v.t. / één studie arm
Blindering
:
Open / niet geblindeerd
Controle
:
N.v.t. / onbekend
Deelname
Nederland
Status
:
Werving gestart
(Verwachte) startdatum
:
Aantal proefpersonen
:
15
Type
:
Verwachte startdatum
Positief advies
Datum
:
Soort
:
Eerste indiening
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
ID: 38209
Bron: ToetsingOnlineAndere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL4410 |
| NTR-old | NTR4652 |
| CCMO | NL36429.041.11 |
| OMON | NL-OMON38209 |
Samenvatting resultaten
1. Korteweg MA, Veldhuis WB, Visser F, Luijten PR, Mali WP, van Diest PJ, van den Bosch MA, Klomp DWJ. Feasibility of 7 Tesla Breast Magnetic Resonance Imaging Determination of Intrinsic Sensitivity and High-Resolution Magnetic Resonance Imaging, Diffusion-Weighted Imaging, and 1H-Magnetic Resonance Spectroscopy of Breast Cancer Patients Receiving Neoadjuvant Therapy. Invest Radiol. 2011 Jun;46(6):370-6.<br>
2. Klomp DW, van de Bank BL, Raaijmakers A, Korteweg MA, Possanzini C, Boer VO, van de Berg CA, van de Bosch MA, Luijten PR. (31) P MRSI and (1) H MRS at 7 T: initial results in human breast cancer. NMR Biomed. 2011 Dec;24(10):1337-42<br>
3. . Boer VO, Vd Bank BL, van Vliet G, Luijten PR, Klomp DW. Direct B(0) field monitoring and real-time B(0) field updating in the human breast at 7 tesla. Magn Reson Med. 2011 Dec 12. doi: 10.1002/mrm.23272. [Epub ahead of print]<br>
4. van der Kemp WJ, Boer VO, Luijten PR, Wijnen JP, Klomp DW. Increase in SNR for (31) P MR spectroscopy by combining polarization transfer with a direct detection sequence. Magn Reson Med. 2011 Dec 12. doi: 10.1002/mrm.23260. [Epub ahead of print]<br>
5. Wijnen JP, van der Kemp WJ, Luttje MP, Korteweg MA, Luijten PR, Klomp DW. Quantitative (31) P magnetic resonance spectroscopy of the human breast at 7 T. Magn Reson Med. 2011 Dec 28. doi: 10.1002/mrm.23249. [Epub ahead of print]<br>
6. van de Bank BL, Voogt IJ, Italiaander M, Stehouwer BL, Boer VO, Luijten PR, Klomp DW. Ultra high spatial and temporal resolution breast imaging at 7T. NMR Biomed. 2012 Oct 18. doi: 10.1002/nbm.2868. [Epub ahead of print]<br>
7. de Graaf RA, Klomp DW, Luijten PR, Boer VO. Intramolecular zero-quantum-coherence 2D NMR spectroscopy of lipids in the human breast at 7 T. Magn Reson Med. 2013 Mar 6. doi: 10.1002/mrm.24701. [Epub ahead of print]<br>
8. van der Kemp WJ, Boer VO, Luijten PR, Stehouwer BL, Veldhuis WB, Klomp DW. Adiabatic multi-echo 31 P spectroscopic imaging (AMESING) at 7 T for the measurement of transverse relaxation times and regaining of sensitivity in tissues with short T2 * values. NMR Biomed. 2013 Apr 2 doi: 10.1002/nbm.2952. [Epub ahead of print]<br>
9. Klomp DW, Dula AN, Arlinghaus LR, Italiaander M, Dortch RD, Zu Z, Williams JM, Gochberg DF, Luijten PR, Gore JC, Yankeelov TE, Smith SA. Amide proton transfer imaging of the human breast at 7T: development and reproducibility. NMR Biomed. 2013 Apr 4. doi: 10.1002/nbm.2947. [Epub ahead of print]<br>
10.Stehouwer BL, Klomp DW, van den Bosch MA, Korteweg MA, Gilhuijs KG, Witkamp AJ, van Diest PJ, Houwert KA, van der Kemp WJ, Luijten PR, Mali WP, Veldhuis WB. Dynamic contrast-enhanced and ultra-high-resolution breast MRI at 7.0 Tesla. Eur Radiol. 2013 Nov;23(11):2961-8. doi: 10.1007/s00330-013-2985-9. Epub 2013 Aug 28.<br>
11. de Leeuw H, Stehouwer BL, Bakker CJ, Klomp DW, van Diest PJ, Luijten PR, Seevinck PR, van den Bosch MA, Viergever MA, Veldhuis WB. Detecting breast microcalcifications with high-field MRI. NMR Biomed. 2014 Feb 17. doi: 10.1002/nbm.3089<br>
12. 31P magnetic resonance spectroscopy of the breast and the influence of the menstrual cycle. Stehouwer BL, van der Kemp WJ, Luijten PR, van den Bosch MA, Veldhuis WB, Wijnen JP, Klomp DW.Breast Cancer Res Treat. 2014 Feb 26.<br>
13. Boer VO, Luttje MP, Luijten PR, Klomp DW. Requirements for static and dynamic higher order B0 shimming of the human breast at 7 T. NMR Biomed. 2014 Feb 25. doi: 10.1002/nbm.3096<br>
14. Korteweg MA, Veldhuis WB, Mali WP, Diepstraten SC, Luijten PR, van den Bosch MA, Eijkemans RM, van Diest PJ, Klomp DW. Investigation of lipid composition of dissected sentinel lymph nodes of breast cancer patients by 7T proton MR spectroscopy. J Magn Reson Imaging. 2011 Oct 3. doi: 10.1002/jmri.22820. [Epub ahead of print]<br>
15. Stehouwer BL, Klomp DW, Korteweg MA, Verkooijen HM, Luijten PR, Mali WP, van den Bosch MA, Veldhuis WB. 7T versus 3T contrast-enhanced breast Magnetic Resonance Imaging of invasive ductulolobular carcinoma: First clinical experience. Magn Reson Imaging. 2012 Oct 30. doi:pii: S0730-725X(12)00359-1. 10.1016/j.mri.2012.09.005. [Epub ahead of print]
2. Klomp DW, van de Bank BL, Raaijmakers A, Korteweg MA, Possanzini C, Boer VO, van de Berg CA, van de Bosch MA, Luijten PR. (31) P MRSI and (1) H MRS at 7 T: initial results in human breast cancer. NMR Biomed. 2011 Dec;24(10):1337-42<br>
3. . Boer VO, Vd Bank BL, van Vliet G, Luijten PR, Klomp DW. Direct B(0) field monitoring and real-time B(0) field updating in the human breast at 7 tesla. Magn Reson Med. 2011 Dec 12. doi: 10.1002/mrm.23272. [Epub ahead of print]<br>
4. van der Kemp WJ, Boer VO, Luijten PR, Wijnen JP, Klomp DW. Increase in SNR for (31) P MR spectroscopy by combining polarization transfer with a direct detection sequence. Magn Reson Med. 2011 Dec 12. doi: 10.1002/mrm.23260. [Epub ahead of print]<br>
5. Wijnen JP, van der Kemp WJ, Luttje MP, Korteweg MA, Luijten PR, Klomp DW. Quantitative (31) P magnetic resonance spectroscopy of the human breast at 7 T. Magn Reson Med. 2011 Dec 28. doi: 10.1002/mrm.23249. [Epub ahead of print]<br>
6. van de Bank BL, Voogt IJ, Italiaander M, Stehouwer BL, Boer VO, Luijten PR, Klomp DW. Ultra high spatial and temporal resolution breast imaging at 7T. NMR Biomed. 2012 Oct 18. doi: 10.1002/nbm.2868. [Epub ahead of print]<br>
7. de Graaf RA, Klomp DW, Luijten PR, Boer VO. Intramolecular zero-quantum-coherence 2D NMR spectroscopy of lipids in the human breast at 7 T. Magn Reson Med. 2013 Mar 6. doi: 10.1002/mrm.24701. [Epub ahead of print]<br>
8. van der Kemp WJ, Boer VO, Luijten PR, Stehouwer BL, Veldhuis WB, Klomp DW. Adiabatic multi-echo 31 P spectroscopic imaging (AMESING) at 7 T for the measurement of transverse relaxation times and regaining of sensitivity in tissues with short T2 * values. NMR Biomed. 2013 Apr 2 doi: 10.1002/nbm.2952. [Epub ahead of print]<br>
9. Klomp DW, Dula AN, Arlinghaus LR, Italiaander M, Dortch RD, Zu Z, Williams JM, Gochberg DF, Luijten PR, Gore JC, Yankeelov TE, Smith SA. Amide proton transfer imaging of the human breast at 7T: development and reproducibility. NMR Biomed. 2013 Apr 4. doi: 10.1002/nbm.2947. [Epub ahead of print]<br>
10.Stehouwer BL, Klomp DW, van den Bosch MA, Korteweg MA, Gilhuijs KG, Witkamp AJ, van Diest PJ, Houwert KA, van der Kemp WJ, Luijten PR, Mali WP, Veldhuis WB. Dynamic contrast-enhanced and ultra-high-resolution breast MRI at 7.0 Tesla. Eur Radiol. 2013 Nov;23(11):2961-8. doi: 10.1007/s00330-013-2985-9. Epub 2013 Aug 28.<br>
11. de Leeuw H, Stehouwer BL, Bakker CJ, Klomp DW, van Diest PJ, Luijten PR, Seevinck PR, van den Bosch MA, Viergever MA, Veldhuis WB. Detecting breast microcalcifications with high-field MRI. NMR Biomed. 2014 Feb 17. doi: 10.1002/nbm.3089<br>
12. 31P magnetic resonance spectroscopy of the breast and the influence of the menstrual cycle. Stehouwer BL, van der Kemp WJ, Luijten PR, van den Bosch MA, Veldhuis WB, Wijnen JP, Klomp DW.Breast Cancer Res Treat. 2014 Feb 26.<br>
13. Boer VO, Luttje MP, Luijten PR, Klomp DW. Requirements for static and dynamic higher order B0 shimming of the human breast at 7 T. NMR Biomed. 2014 Feb 25. doi: 10.1002/nbm.3096<br>
14. Korteweg MA, Veldhuis WB, Mali WP, Diepstraten SC, Luijten PR, van den Bosch MA, Eijkemans RM, van Diest PJ, Klomp DW. Investigation of lipid composition of dissected sentinel lymph nodes of breast cancer patients by 7T proton MR spectroscopy. J Magn Reson Imaging. 2011 Oct 3. doi: 10.1002/jmri.22820. [Epub ahead of print]<br>
15. Stehouwer BL, Klomp DW, Korteweg MA, Verkooijen HM, Luijten PR, Mali WP, van den Bosch MA, Veldhuis WB. 7T versus 3T contrast-enhanced breast Magnetic Resonance Imaging of invasive ductulolobular carcinoma: First clinical experience. Magn Reson Imaging. 2012 Oct 30. doi:pii: S0730-725X(12)00359-1. 10.1016/j.mri.2012.09.005. [Epub ahead of print]